Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: A randomised study

Lancet

Volumn 361, Issue 9376, 2003, Pages 2189-2195

  Veenhoven, Reinier ^a   Bogaert, Debby ^b   Uiterwaal, Cuno ^c   Brouwer, Carole ^a   Kiezebrink, Herma ^a   Bruin, Jacob ^d   IJzerman, Ed ^d   Hermans, Peter ^b   De Groot, Ronald ^b   Zegers, Ben ^e   Kuis, Wietse ^e   Rijkers, Ger ^e   Schilder, Anne ^e   Sanders, Elisabeth ^e  

^a Department of Orthopaedic Surgery   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Laboratory of Public Health Haarlem   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; SEROTYPE; THROAT CULTURE;

EID: 0012642994     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13772-5     Document Type: Article

References (30)

1. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis (RE9960). Pediatrics 2000; 106: 362-66.
2. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 19:2000;187-195.
3. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 344:2001;403-409.
4. Herrod H.G., Gross S., Insel R. Selective antibody deficiency to Haemophilus influenzae type B capsular polysaccharide vaccination in children with recurrent respiratory tract infection. J Clin Immunol. 9:1989;429-434.
5. Prellner K., Harsten G., Lofgren B., Christenson B., Heldrup J. Responses to rubella, tetanus, and diphtheria vaccines in otitis-prone and non-otitis-prone children. Ann Otol Rhinol Laryngol. 99:1990;628-632.
6. Sanders E.A.M., Rijkers G.T., Tenbergen-Meekes A.M., Voorhorst-Ogink M.M., Zegers B.J.M. Immunoglobulin isotype specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent respiratory tract infections. Pediatric Research. 37:1995;812-819.
7. Sanders E.A.M., Van de Winkel J.G., Rijkers G.T., et al. Fc receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis. 170:1994;854-861.
8. Koch A., Melbye M., Sørensen P., et al. Acute respiratory tract infections and mannose-binding lectin insufficiency. JAMA. 285:2001;1348-1355.
9. Kilpi T., Herva E., Kaijalainen T., Syrjänen R.K., Takala A.K. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 20:2001;654-662.
10. O'Brien K.L., Steinhoff M.C., Edwards K., Keyserling H., Thomas M.L., Madore D. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide vaccines. Pediatr Infect Dis J. 15:1996;425-430.
11. Breukels M.A., Rijkers G.T., Voorhorst-Ogink M.M., Zegers B.J.M., Sanders E.A.M. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. J Infect Dis. 179:1999;1152-1156.
12. Appelman C.L.M., Bossen P.C., Dunk J.H.M., van de Lisdonk E.H., de Melkert R.A., van Weert H.C.P.M. Standaard M09, Nederlands Huisartsen Genootschap: otitis media acuta. Huisarts Wet. 33:1990;242-245.
13. Musher D.M., Luchi M.J., Watson D.A., Hamilton R., Baughn R.E. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 161:1990;728-735.
14. Alho O.P. The validity of questionnaire reports of a history of acute otitis media. Am J Epidemiol. 132:1990;1164-1170.
15. Alho O.P., Laara E., Oja H. What is the natural history of recurrent acute otitis media in infancy? J Fam Pract. 43:1996;258-264.
16. Kleijnen J., de Craen A.J., van Everdingen J., Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet. 344:1994;1347-1349.
17. Maly R.C., Bourque L.B., Engelhard R.F. A randomized controlled trial of facilitating information giving to patients with chronic medical conditions: effects on outcomes of care. J Fam Pract. 48:1999;356-363.
18. Kilpi T, Palmu A, Jokinen J, Kähty H, Mäkela. Efficacy of conjugate vaccine against acute otitis media (AOM) - Finnish Experience. In: Program and abstracts of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases, Anchorage, May 5-8, 2002: 110 (abstr).
19. Kalm O., Prellner K., Freijd A., Rynnel-Dagoo B. Antibody activity before and after pneumococcal vaccination of otitis-prone and non-otitis-prone children. Acta Otolaryngol. 101:1986;467-474.
20. Dagan R., Givon-Lavi N., Zamir O., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 185:2002;927-936.
21. Syrjänen R.K., Kilpi T.M., Kaijalainen T.H., Herva E.E., Takala A.K. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish Children younger than 2 years old. J Infect Dis. 184:2001;451-459.
22. Obaro S.K., Adegbola R.A., Banya W.A., Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination. Lancet. 348:1996;271-272.
23. Dagan R., Sikuler-Cohen M., Zamir O., Janco J., Givon-Lavi N., Fraser D. Effect of conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 20:2000;951-958.
24. Lipsitch M., Dykes J.K., Johnson S.E., Ades E.W., King J., Briles D.E., Carlone G.M. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine. 18:2000;2895-2901.
25. Spratt B.G., Greenwood B.M. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet. 356:2000;1210-1211.
26. Douglas R.M., Miles H.B. Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children. J Infect Dis. 149:1984;861-870.
27. Rosen C., Christensen P., Hovelius B., Prellner K. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres. Acta Otolaryngol. 98:1984;524-532.
28. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis. 175:1997;1140-1145.
29. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic Studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first months of life. J Infect Dis. 142:1980;923-933.
30. Giebink G. The microbiology of otitis media. Pediatr Infect Dis J. 8:1989;S18-S20.